Discover the full directors' dealings record of 우정바이오, a listed issuer based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Healthcare sector, 우정바이오 has published 3 insider filings. Market capitalisation: €46.7bn. The latest transaction was reported on 3 April 2026 — Other. Among the most active insiders: 콜마홀딩스. Every trade is openly available.